Menu
Washingtoner
  • Home
  • Financial
  • Technology
  • Home
  • Education
  • Business
  • Construction
  • Services
  • Marketing
Washingtoner

FreezeNit Announces Exclusive Licensing of Novel Non-Toxic Lice Treatment Technology
Washingtoner/10287890

Trending...
  • Spokane City Council Members Introduce "Immigration Enforcement Free Zones"
  • Welfare Check Leads To Domestic Violence Arrest; Guns and Drugs Recovered At North Spokane Apartment
  • New Threat Management Workshop Brings Hands-On BTAM Training to Spokane Valley
FreezeNit
Naturally-Derived OTC Gel Eliminates Lice Without Neurotoxins, Launching Spring 2025

MARBLEHEAD, Mass. - Washingtoner -- FreezeNit, a leader in innovative lice treatment solutions, is thrilled to announce the exclusive licensing of a novel over-the-counter (OTC) lice treatment gel designed to provide a safe, naturally-derived, and highly effective alternative to traditional synthetic or pesticide-based lice treatments.

Unlike conventional OTC lice treatments that rely on pesticide-based pyrethroids, which have decreasing efficacy due to lice resistance, this new technology works by a purely mechanical method of action to eliminate lice and their eggs. The patented formula is free from harsh chemicals and instead leverages natural abrasives, such as diatomaceous earth and walnut shell powder, orange oil extract, and conditioning agents to physically shred lice and nits, while being gentle on the hair and scalp.

This addition strengthens FreezeNit's growing product portfolio, reinforcing the company's mission to provide clean, effective, science-backed treatments that parents can trust.

"This is an incredibly exciting milestone for FreezeNit," said Joanna Shu, CEO of FreezeNit. "By securing exclusive rights to this novel technology, we're positioned to be on the cutting edge of first aid treatments that are gentle on kids. Traditional lice treatments have failed parents and kids, but with this gel, lice don't stand a chance."

More on Washingtoner
  • HBMHCW Expande Infraestructura de Cumplimiento para Argentina mientras América Latina Supera $1.5 Billones en Volumen Cripto
  • Norisia Launches AI Formulated Luxury Multivitamin to Transform Daily Wellness in the UK
  • City of Tacoma Invites Community Input on Proposals to Modernize Housing, Zoning, and Land Use Codes for 2026
  • Tacoma: Mayor Anders Ibsen to Deliver First State of the City Address on March 4
  • Jacob Emrani's Annual "Supper Bowl" Expected To Donate Thousands Of Meals

✔ Clinically Proven – was shown to be 96% effective in a clinical trial.
✔ No Resistance Issues – Unlike permethrin-based treatments, which have seen increased lice resistance, this technology works mechanically—not chemically—so lice cannot develop immunity.
✔ Patented & Protected – This novel formula and method of action is patented in the U.S., Canada, and the EU, ensuring exclusivity in the market.
✔ Class I, 510(k) Exempt – The FDA-regulated status allows for a fast-tracked market entry.

FreezeNit is actively engaging with retailers, distributors, and healthcare providers to bring this breakthrough lice treatment to families everywhere.

FreezeNit is an innovative healthcare company dedicated to revolutionizing first-aid with safe, effective, and science-backed solutions. By leveraging cutting-edge technology and natural alternatives to neurotoxins, FreezeNit provides families with fast, reliable, and pesticide-free treatments for head lice infestations.  For more information, visit www.FreezeNit.com.

Media Contact
Cathy Henry
cathy@freezenit.com
214-924-5992


Source: FreezeNit

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on Washingtoner
  • Stolen Hearts: Reclaiming Your Child From Parental Alienation (narcissistic abuse)
  • Roshni Online Services Unveils Plans for Innovative Digital Consultation Platform
  • City of Tacoma Offers In-Person Workshop for Local Businesses on the Revolving Loan Fund Process
  • Wall Street Is Missing This One: Cycurion (NAS DAQ: CYCU) Gets $7 Price Target While Trading at a Steep Discount
  • Aries Industries Streamlines Sewer Inspection Process With Introduction of the LETS Sidewinder
  • Chronic Boss Awards Scholarships to Student Founders Living with Chronic Conditions
  • Nest Finders Property Management Named #1 in Jacksonville and Ranked #99 Nationwide
  • City Council Confirms Appointment of Patti Jackson as Tacoma's Police Chief
  • Nashville International Chopin Piano Competition Launches First Amateur Edition
  • Council Votes on Pathways to Eviction Prevention for Spokane
  • Market Value Enhancement From 2 Important New US Patents Issued for Strengthening Hair Enzyme Booster Technology to Caring Brands (NAS DAQ: CABR)
  • HELM Audio™ Partners with PQCrypto to Future-Proof Children's Hearing and Safety Data Using Post-Quantum Cryptography
  • Wala Blegay to Announce Run for Congress in Maryland's 5th District on Feb. 4
  • Luxury Lake-View Home Launches in Kissimmee's Bellalago community, Offering Privacy, Space, and Florida Resort-Style Living
  • Sleep Basil Launches Revamped Diamond Mattress Collection Page, Highlighting Performance, Craftsmanship, and Personalized Comfort
  • Sleep Basil Curates a Clearer Brooklyn Bedding Experience for Performance-Minded Denver Sleepers
  • Spokane City Council Members Introduce "Immigration Enforcement Free Zones"
  • Spokane: Mayor Brown Calls on Congress to Extend Temporary Protected Status for Haitian Community Members
  • Nevada Man Launches Nationwide Animal Abuse Registry
  • New Threat Management Workshop Brings Hands-On BTAM Training to Spokane Valley
_catLbl0 _catLbl1

Popular on Washingtoner

  • Spokane: Council to Hold Press Conference to Discuss Further Information on Department of Justice Grant - 112
  • Spokane: Council Members Official Swearing In Ceremony
  • TBM Council Appoints U.S. Department of Transportation CDIO Pavan Pidugu to Board of Directors
  • Spokane: Mayor Brown Appoints New Emergency Communications Director
  • New Analysis Reveals Most Patients Discontinue Weight Loss Drugs Within First Year
  • Trends Journal's Top Trends of 2026
  • Spokane: Male In Custody After Domestic Violence Court Order Service Results In Emergent Entry Into A Residence; Multiple Firearms Recovered
  • "Phinge Unveil™" Coming to Las Vegas to Showcase Netverse Patented Verified App-less Platform, AI & Modular Hardware Including Developer Conferences
  • David Boland, Inc. Awarded $54.3M Construction Contract by U.S. Army Corps of Engineers, Savannah District
  • Tacoma: City Offers Virtual Workshop Series for Small Businesses on AI and Cybersecurity

Similar on Washingtoner

  • Parkway Prosthodontics Achieves Breakthrough Full-Arch Reconstruction Case
  • Norisia Launches AI Formulated Luxury Multivitamin to Transform Daily Wellness in the UK
  • Half of Finnish Online Gambling Expenditure Now Flows to Offshore Instant Casinos as License Applications Open March 1, 2026
  • EPP Pricing Platform announces leadership transition to support long-term growth and continuity
  • Stolen Hearts: Reclaiming Your Child From Parental Alienation (narcissistic abuse)
  • Roshni Online Services Unveils Plans for Innovative Digital Consultation Platform
  • Chronic Boss Awards Scholarships to Student Founders Living with Chronic Conditions
  • Market Value Enhancement From 2 Important New US Patents Issued for Strengthening Hair Enzyme Booster Technology to Caring Brands (NAS DAQ: CABR)
  • Wala Blegay to Announce Run for Congress in Maryland's 5th District on Feb. 4
  • Sleep Basil Launches Revamped Diamond Mattress Collection Page, Highlighting Performance, Craftsmanship, and Personalized Comfort
Copyright © 2026 washingtoner.com | Terms of Service | Privacy Policy | Contact Us | Contribute